Whipplewood Advisors, LLC Crispr Therapeutics Ag Transaction History
Whipplewood Advisors, LLC
- $169 Billion
- Q1 2025
A detailed history of Whipplewood Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 5 shares of CRSP stock, worth $190. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5
Previous 4,037
99.88%
Holding current value
$190
Previous $159 Million
13.54%
% of portfolio
0.08%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$387 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$231 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$144 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$106 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$96.6 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.97B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....